Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Auxilium
says FDA approved hand drug Xiaflex 2:31 PM 2/3/2010
BusinessWeek
Auxilium Pharmaceuticals received US FDA marketing approval for a drug to treat a
condition that constricts the fingers and causes them to bend inward.
...
Neurosearch
shares leap on Huntington's drug study 5:31 AM 2/3/2010
Reuters
Danish biopharmaceuticals firm Neurosearch A/S announced positive results from a Phase
III trial with drug candidate Huntexil for Huntington's disease.
...
Glaxo
in up to $330 million deal with Austrian biotech 3:21 AM 2/3/2010
Reuters
GlaxoSmithKline has bought rights to Apeiron Biologics' APN01 experimental
medicine in Phase I development for the treatment of acute respiratory distress syndrome.
...
FDA
to review Teva biosimilar of Amgen's Neupogen 10:14 AM 2/2/2010
Reuters
The US FDA accepted Teva Pharmaceutical Industries Ltd's Biologics License
Application for a drug similar to Amgen Inc's Neupogen. XM02 (to be branded Neutroval) is already being sold
under the name TevaGrastim in several European countries. FDA application treats XM02 as a new product.
...
Onyx
says FDA agrees on blood cancer drug trial design 9:19 AM 2/2/2010
Reuters
Onyx Pharmaceuticals Inc reached an agreement with the US FDA on the
design of the late-stage trial of its blood cancer drug carfilzomib in combination with certain other compounds.
...
Lancet
Formally Retracts Study Linking Child Vaccine to
Autism 7:54 AM 2/2/2010
Bloomberg
The
Lancet medical journal retracts a study that linked a routine childhood vaccine to autism and bowel disease
after an investigation found the original 1998 paper was flawed.
...
Protalix
says FDA seeks more data on Gaucher drug 5:07 AM 2/2/2010
Reuters
The US FDA would like additional manufacturing information on Protalix Biotherapeutics
Inc's experimental drug for Gaucher disease.
...
Herbal
remedies, heart drugs don't mix: review 5:08 PM 2/1/2010
Reuters
Ginkgo biloba, St. John's wort, and other herbal supplements may increase the potency
of prescription drugs for heart disease or make them less effective.
...
Cephalon
to buy Mepha 10:15 AM 2/1/2010
Bizjournals.com
Cephalon Inc will buy generic and branded pharmaceutical firm Mepha AG of
Switzerland in a deal that will double Cephalon's international business. Mepha markets 120 products in 50
countries with 50 pipeline drugs that could be ready within five years.
...
Scientists
say crack HIV/AIDS puzzle for drugs 5:10 PM 1/31/2010
Reuters
British and US researchers have grown a crystal that enable them to see the structure
of the integrase enzyme which is found in retroviruses like HIV and is a target for some of the newest HIV
medicines.
...
Glaxo
to cut more jobs as generics bite-reports 11:37 AM 1/31/2010
Reuters
GlaxoSmithKline plans to cut up to 4,000 jobs as competition from new generic drugs
weighs on sales.
...
Gates
pledges $10bn for vaccine development 6:27 AM 1/31/2010
Financial Times
Bill Gates pledged to give $10 billionn over the next 10 years split between
accelerating delivery of existing vaccines in the poorest countries and development of new vaccines for killer
infectious diseases.
...
Scientists
a step closer to human vaccine for chikungunya virus 11:34 AM 1/30/2010
Los Angeles Times
US researchers have developed a prototype vaccine that
protects monkeys and mice against the emerging chikungunya virus which is mosquito-borne and causes rash, a high
fever, and a severe arthritis that can persist for years.
...
FDA
OKs expanded use of Glaxo breast cancer drug 4:02 PM 1/29/2010
Reuters
The US FDA broadened the approval of GlaxoSmithKline's breast cancer drug
Tykerb to be used in combination with the Novartis breast cancer drug Femara to treat hormone positive and
HER2-positive advanced breast cancer in post-menopausal women.
...
Theravance
reports new delay in infection drug OK 4:01 AM 1/29/2010
BusinessWeek
The US FDA is not satisfied with Theravance Inc's new data on infection drug
candidate Vibativ. Further clinical study may be required to win marketing approval.
...
<- Day Earlier | Today's News
|
